- Home
- UPXI vs FORA Comparison
UPXI vs FORA Comparison
Compare UPXI & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$0.96
N/A
Current Price
$2.08
Company Overview
Basic Information| Metric | UPXI | FORA |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.6M | 66.2M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | UPXI | FORA |
|---|---|---|
| Price | $0.96 | $2.08 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 5.9M | 16.6K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.49 | N/A |
| EPS | ★ 0.76 | N/A |
| Revenue | $15,811,345.00 | ★ $20,153,263.00 |
| Revenue This Year | $118.99 | $51.82 |
| Revenue Next Year | N/A | $7.24 |
| P/E Ratio | $1.18 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.54 | $1.64 |
| 52 Week High | $22.53 | $2.71 |
Technical Indicators
Market Signals| Indicator | UPXI | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 45.56 | 46.32 |
| Support Level | $0.54 | $2.05 |
| Resistance Level | $2.46 | $2.12 |
| Average True Range (ATR) | 0.13 | 0.02 |
| MACD | 0.08 | 0.00 |
| Stochastic Oscillator | 63.22 | 40.00 |
Price Performance
Historical Comparison UPXI
FORA
About UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via Solana. Geographically, the company generates the majority of its revenue from the United States.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.